土耳其Alvimedica
Alvimedica拥有自主研发的心脏病学介入性心脏血管成形术和SDS气球导管(支架递送系统)，拥有欧洲最大的“10.000级”净化室，并在荷兰还拥有一所现代化的研发机构，目前，该公司已向40多个国家出口其产品。


Alvimedica is the first and the only manufacturing company in Turkey in the field of interventional cardiology with catheters and stents it has developed itself. The company designs, develops and manufactures mainly cardiologic angioplasty balloon catheters and SDS (Stent Delivery Systems).

Certified Quality Assurance Processes
All Alvimedica’s products possess CE certificates. In addition, the quality continuity of the production facilities and the conditions of production are inspected every year by Intertek Amtac, which has UK’s approval. As a consequence of such inspections, regular amelioration and quality continuity of the system are attained.

Product Range that Fits the Purpose
The product line of Alvimedica consists of a whole range of single-use invasive cardiology devices. They are all suitable for different, special and specific cases. There are many clinical studies, which have been published in a variety of prestigious scientific journals, proving the efficacy and safety of the products.

High Production Volume
Alvimedica moved its production facilities to Istanbul Trakya Free Zone in February 2009 where it continues operating with an increased production volume in a 5.500 m2 area.

With its newly established Class 100.000 clean-room, one of the biggest clean-rooms in Europe, the company has quadrupled its previous production volume.

High Technology Employment
Alvimedica runs its production operations end to end, from raw materials to the finished product, in its new production facility. The production takes place on lines equipped with highly sophisticated machines and tools in compliance with GMP’s strict regulations -ensuring a high quality manufacturing practice.

Innovation and Expertise
Alvimedicais headquartered in Copenhagen, Denmark. The company’s location area is known as the medical device industry’s Silicon Valley where Research & Development of the medical devices take place.

Within its permanent staff, Alvimedica employs academics and research associates who are experts in their own fields. The company also collaborates with relevant university departments inland and abroad and works with them on a project basis. Under the supervision of their highly qualified scientists and experts, the company executes product R&D projects.

By building international partnerships with high-tech and innovative companies from all around the world,Alvimedicacontinuously improves the technology in its production operations.

Wide Distribution Network
Alvimedica aims to reach clinics all over the world which are accessible to interventional cardiologists and patients who have heart diseases.With this purpose in mind, the company expanded its international distribution network to 17 countries as of February, 2009. By the end of 2010, the company plans to increase this number to 70 countries.